Biotech Intelligence
Tuesday, September 1, 2020
Interviews with Cytodyn: Nader Pourhassan, CEO and Scott Kelly, Chairman
›
The Investment Idea Behind It All The bet is that an investment in a biotech, CytoDyn ( CYDY ), with a single drug with multiple applicati...
9 comments:
Friday, June 12, 2020
Cytodyn's Great Prospects
›
Cytodyn is a triple threat with one drug, leronlimab. First, is its work on HIV over the past years. Over 800 patients were tested, and ...
1 comment:
›
Home
View web version